scispace - formally typeset
J

J. Godfrey

Researcher at Simon Fraser University

Publications -  331
Citations -  38250

J. Godfrey is an academic researcher from Simon Fraser University. The author has contributed to research in topics: Large Hadron Collider & Lepton. The author has an hindex of 95, co-authored 323 publications receiving 36847 citations. Previous affiliations of J. Godfrey include Istanbul Technical University & West University of Timișoara.

Papers
More filters

Measurement of the centrality dependence of the charged-particle pseudorapidity distribution in proton–lead collisions at \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\sqrt{s_{_\text {NN}}} = 5.02$$\end{document}sNN=5.02 TeV with the ATLAS detector

Georges Aad, +2827 more

Measurement of W[superscript +]W[superscript -] production in pp collisions at √s=7 TeV with the ATLAS detector and limits on anomalous WWZ and WWγ couplings

Georges Aad, +2900 more

Measurement of the production cross-section of ψ(2S) → [J over ψ](→μ[superscript +] μ[superscript −]) π[superscript +] π [superscript −] in pp collisions at √s = 7 TeV at ATLAS

Georges Aad, +2856 more

Letter of Intent by the Solenoidal Detector Collaboration to Construct and Operate A Detector at the Superconducting Super Collider

G. H. Trilling, +682 more
Journal ArticleDOI

P.120 Unlocking the potential of oligonucleotide therapeutics for Duchenne muscular dystrophy through enhanced delivery

Michelle Mellion, +12 more
- 01 Oct 2022 - 
TL;DR: PGN-EDO51 is a clinical candidate to treat individuals with Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping as mentioned in this paper , which is the first of a series of therapies based on the Enhanced Delivery Oligonucleotide (EDO) platform.